[PDF][PDF] Cell Block Technique and Cytological Smears for the Differential Diagnosis of Pancreatic Neoplasms after EUS-guided Fine-Needle Aspiration (EUS-FNA)
JC Ardengh, CV Lopes, LFP De Lima… - Acta gastroenterologica …, 2008 - redalyc.org
Cytological smear is widely employed to analyse specimens obtained from endosonography-
guided fine-needle aspiration (EUS-FNA), but false-negative or inconclusive results may …
guided fine-needle aspiration (EUS-FNA), but false-negative or inconclusive results may …
[HTML][HTML] Ultrasound-guided vs endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer diagnosis
M Matsuyama, H Ishii, K Kuraoka… - World Journal of …, 2013 - ncbi.nlm.nih.gov
AIM: To clarify the effectiveness and safety of endoscopic ultrasound-guided fine-needle
aspiration (EUS-FNA) for the diagnosis of pancreatic cancer (PC). METHODS: Patients who …
aspiration (EUS-FNA) for the diagnosis of pancreatic cancer (PC). METHODS: Patients who …
[HTML][HTML] Prognostic Value of Human Equilibrative NucleosideTransporter1 in Pancreatic Cancer Receiving Gemcitabin-Based Chemotherapy: A Meta-Analysis
ZQ Liu, YC Han, X Zhang, L Chu, JM Fang, HX Zhao… - PloS one, 2014 - journals.plos.org
Background The potential prognostic value of human equilibrative nucleoside transporter1
in pancreatic cancer receiving gemcitabine-based chemotherapy is variably reported …
in pancreatic cancer receiving gemcitabine-based chemotherapy is variably reported …
Management of pancreatic masses
D Wolfson, JS Barkin, ST Chari, JE Clain, RH Bell Jr… - Pancreas, 2005 - journals.lww.com
Dr. William M. Steinberg Traditionally, the approach to the patient presenting with a
resectable mass in the pancreas has been to take the patient to surgery without a …
resectable mass in the pancreas has been to take the patient to surgery without a …
Repeat Endoscopic Ultrasound‐Guided Fine‐Needle Aspiration in Patients with Suspected Pancreatic Cancer: Diagnostic Yield and Associated Change in Access to …
RA Mitchell, D Stanger, C Shuster… - Canadian Journal of …, 2016 - Wiley Online Library
Background. There is a high incidence of inconclusive cytopathology at initial EUS‐FNA
(endoscopic ultrasound‐guided fine‐needle aspiration) for suspected malignant pancreatic …
(endoscopic ultrasound‐guided fine‐needle aspiration) for suspected malignant pancreatic …
[HTML][HTML] Diagnostic and prognostic biomarkers in pancreatic carcinoma
JJ Liang, ET Kimchi… - International journal of …, 2009 - ncbi.nlm.nih.gov
Pancreatic ductal carcinoma, one of the leading causes of cancer mortality, is typically
diagnosed at an advanced stage, which significantly contributes to its high mortality rates …
diagnosed at an advanced stage, which significantly contributes to its high mortality rates …
[HTML][HTML] Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma
J Boujaoude - World Journal of Gastroenterology: WJG, 2007 - ncbi.nlm.nih.gov
Since its advent more than 20 years ago, endoscopic ultrasound (EUS) has undergone
evolution from an experimental to a diagnostic instrument and is now established as a …
evolution from an experimental to a diagnostic instrument and is now established as a …
[HTML][HTML] DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis
JI Plougmann, P Klausen, A Toxvaerd… - Endoscopic …, 2020 - journals.lww.com
Results: Pathogenic mutations in K-RAS, TP53, and PIK3CA differed significantly between
the three groups (P< 0.001, P= 0.018, and P= 0.026, respectively). Pathogenic mutations in …
the three groups (P< 0.001, P= 0.018, and P= 0.026, respectively). Pathogenic mutations in …
[HTML][HTML] Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: A retrospective …
T Ishizawa, N Makino, A Matsuda, Y Kakizaki… - PLoS …, 2020 - journals.plos.org
Pancreatic cancer (PC) is a highly lethal malignancy, with a 5-year survival rate of 6%.
Cancer gene panel testing is expected to allow selection of suitable therapeutic drugs in …
Cancer gene panel testing is expected to allow selection of suitable therapeutic drugs in …
Genetics and prevention of pancreatic cancer
D Vimalachandran, P Ghaneh, E Costello… - Cancer …, 2004 - journals.sagepub.com
Background Pancreatic cancer is an aggressive disease with a poor prognosis. Hereditary
factors have been reported in up to 10% of cases of pancreatic cancer. The clinical …
factors have been reported in up to 10% of cases of pancreatic cancer. The clinical …